Cargando…
Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
BACKGROUND: Long non-coding RNAs (lncRNAs) have emerged as biomarkers and important regulators of tumor development and progression. PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) is a novel long non-coding RNA that acts as a potential biomarker and involves in development of multipl...
Autores principales: | Zhan, Yonghao, Lin, Junhao, Liu, Yuchen, Chen, Mingwei, Chen, Xiaoying, Zhuang, Chengle, Liu, Li, Xu, Wen, Chen, Zhicong, He, Anbang, Zhang, Qiaoxia, Sun, Xiaojuan, Zhao, Guoping, Huang, Weiren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873988/ https://www.ncbi.nlm.nih.gov/pubmed/27206339 http://dx.doi.org/10.1186/s13046-016-0354-7 |
Ejemplares similares
-
Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023) -
Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016) -
Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells
por: Chen, Zhicong, et al.
Publicado: (2016) -
Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2016) -
Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2023)